clinical trial

You have accessRestricted Access
Major Adverse Kidney Events in Pediatric Sepsis
Scott L. Weiss, Fran Balamuth, Cary W. Thurm, Kevin J. Downes, Julie C. Fitzgerald and Benjamin L. Laskin

CJASN April 2019, CJN.12201018; DOI: https://doi.org/10.2215/CJN.12201018

Add to Selected Citations
Open Access
Estimation of Kidney Function in Oncology
Morgan A. Casal, Thomas D. Nolin and Jan H. Beumer

CJASN April 2019, 14 (4) 587-595; DOI: https://doi.org/10.2215/CJN.11721018

Add to Selected Citations
You have accessRestricted Access
Adrenocorticotropic Hormone for Childhood Nephrotic Syndrome
Chia-shi Wang, Curtis Travers, Courtney McCracken, Traci Leong, Rasheed Gbadegesin, Alejandro Quiroga, Mark R. Benfield, Guillermo Hidalgo, Tarak Srivastava, Megan Lo, Ora Yadin, Robert Mathias, Carlos E. Araya, Myda Khalid, Alvaro Orjuela, Joshua Zaritsky, Samhar Al-Akash, Margret Kamel and Larry A. Greenbaum

CJASN December 2018, 13 (12) 1859-1865; DOI: https://doi.org/10.2215/CJN.06890618

Add to Selected Citations
Open Access
Home-Based Kidney Care, Patient Activation, and Risk Factors for CKD Progression in Zuni Indians
Robert G. Nelson, V. Shane Pankratz, Donica M. Ghahate, Jeanette Bobelu, Thomas Faber and Vallabh O. Shah

CJASN December 2018, 13 (12) 1801-1809; DOI: https://doi.org/10.2215/CJN.06910618

Add to Selected Citations
Open Access
Novel Models for Health Care Delivery for CKD for Disadvantaged Populations
Joseph Lunyera and Clarissa Jonas Diamantidis

CJASN December 2018, 13 (12) 1779-1780; DOI: https://doi.org/10.2215/CJN.12591018

Add to Selected Citations
You have accessRestricted Access
Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes
Amy K. Mottl, John B. Buse, Faramarz Ismail-Beigi, Ronald J. Sigal, Carolyn F. Pedley, Vasilios Papademetriou, Debra L. Simmons, Lois Katz, Josyf C. Mychaleckyj and Timothy E. Craven

CJASN November 2018, 13 (11) 1693-1702; DOI: https://doi.org/10.2215/CJN.06200518

Add to Selected Citations
Open Access
Burden of Proof for Tolvaptan in ADPKD
Reem A. Mustafa and Alan S.L. Yu

CJASN July 2018, 13 (7) 1107-1109; DOI: https://doi.org/10.2215/CJN.00190118

Add to Selected Citations
You have accessRestricted Access
Comparative Effects of Cholecalciferol and Calcitriol on Circulating Markers of CKD Mineral Bone Disorder
Leila R. Zelnick, Ian H. de Boer, Bryan R. Kestenbaum, Michel Chonchol and Jessica Kendrick

CJASN June 2018, 13 (6) 927-928; DOI: https://doi.org/10.2215/CJN.00480118

Add to Selected Citations
Open Access
Contrast-Induced Acute Kidney Injury in the PRESERVE Trial
Edward D. Siew and Kathleen D. Liu

CJASN June 2018, 13 (6) 949-951; DOI: https://doi.org/10.2215/CJN.01060118

Add to Selected Citations
Open Access
Burden of Proof for Tolvaptan in ADPKD
Reem A. Mustafa and Alan S.L. Yu

CJASN April 2018, CJN.00190118; DOI: https://doi.org/10.2215/CJN.00190118

Add to Selected Citations

Main menu

User menu

Search

clinical trial

Pages

About

Author Information

More information